Latest research supporting stereotactic radiotherapy for oligometastatic renal cell carcinoma

Author(s):

Urology Times staff

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

At the SUO 23rd Annual Meeting, Raquibul Hannan, MD, PhD, the latest research findings showing positive results with stereotactic radiotherapy in patients with oligometastatic renal cell carcinoma. Hannan is a professor in the Department of Radiation Oncology, Urology and Immunology at the University of Texas Southwestern Medical Center in Dallas.

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Subscribe Now!